Insulin Sensitization by a Novel Partial Peroxisome Proliferator-Activated Receptor γ Agonist With Protein Tyrosine Phosphatase 1B Inhibitory Activity in Experimental Osteoporotic Rats

• Autores principales: Masahiro Kubo (Autor), Masaki Fukui (Autor), Yuma Ito (Autor), Tatsuya Kitao (Autor), Hiroaki Shirahase (Autor), Eiichi Hinoi (Autor), Yukio Yoneda (Autor)
• Formato: Libro
• Publicado: Elsevier, 2014-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The pharmacological profile of (S)-7-(2-{2-[(E)-2-cyclopentylvinyl]-5-methyloxazol-4-yl}-ethoxy)-2-[(2E,4E)-hexadienoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (KY-201), a peroxisome proliferator-activated receptor (PPAR) γ agonist, was compared with that of rosiglitazone in ovariectomized...